…er injury (DILI) due to other medications.Methods Patients with cancer taking immunotherapy who did and did not develop ChILI were rec…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 122 of 2459…ycin vials to capsules for second-line treatment; the rest used fidaxomicin. At the end, 100% of the CDI cases resolved.Conclusion and Rele…
…nd epileptic encephalopathies with limited therapeutic options. Fenfluramine has shown efficacy in DS and LGS, but evidence in other epilept…
…s the impact of migraine, the Headache Impact Test (HIT-6), the Visual Analogue Scale (VAS), and the Patient Global Impression of Change (PGIC) were …
…have doubled progression-free survival. Approved agents include abemaciclib, palbociclib, and ribociclib. In the MONARCH 2 trial, abemacicl…
…mportance The aim of antiretroviral therapy (ART) is to supress HIV replication, thereby reducing the risk of opportunistic infecti…
…cially in diseases with high pharmaceutical expenditure such as transthyretin amyloidosis.Aim and Objectives The aim of this study was to quantify the av…
…These findings extend safety observations beyond semaglutide to tirzepatide. Healthcare providers should consider this potential risk when …
…lin.Material and methods Over four weeks (February–March 2025), insulin prescriptions from adult medical wards (excluding intensive car…
…t (2%), and paediatric (2%).Conclusion and Relevance Nearly all linezolid prescriptions met at least one criterion for TDM, with around 6…
…ease with highly variable manifestations. New therapies such as belimumab appear to reduce cumulative organ damage and disease flares, im…
…Background and Importance Cardio-Renal-Metabolic syndrome results from interactions between cardiovascular, metabolic, an…